Latest filing published 10 Nov 2025 for LAM Research CORP.
Not enough history yet: 0 closed purchases, at least 2 are needed.
The only purchase in John M. Dineen's record dates from July 6, 2020: EUR 454,107 at Syneos Health, Inc., where John M. Dineen sits as Director. No sale appears among the 12 filings, which are mostly 9 share grants, plus one option exercise and one filing of another kind.
Syneos Health, Inc. accounts for 8 filings, LAM Research Corp for 3 and Cognizant Technology Solutions Corp for one, always as Director. Published from December 11, 2018 to November 10, 2025, they form a discreet flow: one or two a year, with a peak of 4 in 2023. Only one filing falls in the last twelve months, with neither a purchase nor a sale. The median publication delay is 2 days. The two companies other than Syneos Health, Inc. carry no purchase or sale at all.
Trades by Dineen within 30 days of colleagues at Syneos Health, Inc. number 1 and 1. Of which in the same direction: 0 and 0. Names in order: Alistair Macdonald and Michelle Keefe.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations